MedPath

EMPOWER: Randomized Trial of Online Chronic Pain Management Program to Reduce Reliance on Opioid Analgesic Medications

Not Applicable
Completed
Conditions
Chronic Pain
Interventions
Behavioral: E-health program
Registration Number
NCT03308188
Lead Sponsor
University of Cincinnati
Brief Summary

This is a 10-month internet-based randomized controlled trial to evaluate whether an online chronic pain management program ("E-Health") can assist with reduced opioid reliance in chronic pain patients. About half of the eligible participants will receive access to the E-Health program in addition to their standard chronic pain treatment; the other half will just continue receiving their standard chronic pain treatment.

Detailed Description

This study will determine whether an innovative, accessible E-health intervention can assist with reduced opioid reliance in chronic pain patients, which can, ultimately, reduce risks of unintended opioid overdose and death. Importantly, the study will contribute to a better understanding of the mechanisms contributing to opioid use reduction while managing pain. The findings may assist in developing treatment options for a population at risk for opioid adverse effects.

Potential participants will be identified through electronic health record (EHR) queries at participating sites. Participants will be assessed at baseline, at the end of the 4-month treatment period, and at 6 months following end-of-treatment through an electronic data capture system accessed by the participants. Other outcome data will be obtained from the participant's EHR data.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
402
Inclusion Criteria
  • Be 25-80 years of age
  • Be able to understand the study, and having understood, provide informed consent in English
  • Have a daily average prescribed MED ≥ 20 mg over a recent three-month period
  • Have a chronic pain-related diagnosis
  • Self-report current use of opioid medication(s) to treat pain
  • Have a Brief Pain Inventory Pain Intensity score ≥3
  • Have internet access and a working email account
Exclusion Criteria
  • Be anyone who, in the judgment of study staff, would be unlikely to complete the study (e.g., planning to change to a different primary care clinic, have a terminal illness, etc.)
  • Be unwilling/unable to complete the WebNeuro assessments
  • Be pregnant
  • Be a prisoner

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
E-Health+E-health programParticipants randomized to the E-health+ arm will receive treatment as typically provided by their clinician plus a 4-month subscription to the E-health program, which is an internet based chronic pain program.
Primary Outcome Measures
NameTimeMethod
Decrease in Morphine Equivalent Dose (MED)Baseline and 10 months

Whether (yes/no) there was a ≥15% decrease in MED, between baseline and 10-month post-randomization follow-up.

Secondary Outcome Measures
NameTimeMethod
Pain IntensityBaseline and 10 months

Whether (yes/no) there is a clinically meaningful decrease in pain intensity (at least 2 points) as measured by the Brief Pain Inventory (BPI), between baseline and 10-month post-randomization follow-up.

Trial Locations

Locations (2)

Duke Health

🇺🇸

Durham, North Carolina, United States

UC Health

🇺🇸

Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath